Release Date: July 7, 2022
Expiration Date: July 7, 2023
This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education.
This activity is supported by independent educational grants from
Bristol Myers Squibb and Genentech.
Target Audience
This activity is designed to meet the educational needs of general neurology physicians, PAs, nurse practitioners, nurses, and other healthcare professionals involved in the treatment of patients with MS.
Program Overview
A series of case reviews that provides participants with scenarios where one or more errors, unsafe practices, or underutilization of newer therapies when appropriate have occurred. The goal is to provide real-life examples of suboptimal treatment for MS patients and to challenge non-MS specialists to identify areas for improvement.
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
- Nurses — 1.0 contact hours of nursing continuing professional development credit (NCPD) (1.0 in the area of pharmacology)
- Pharmacists — 1.0 contact hours (0.10 CEUs) of continuing pharmacy education credit.
All other healthcare professionals completing this course will be issued a statement of participation.
Contact Information
For questions about this activity, please contact Catamount Medical Education at [email protected].